Sofinnova Ventures »

IsoRay shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of IsoRay (CATX) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in IsoRay

Tip: Access up to 7 years of quarterly data

All positions including IsoRay held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IsoRay by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $512k 430k 1.19

More positions owned by Sofinnova Ventures

Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Natera (NTRA)
Edwards Lifesciences (EW)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Novo-Nordisk A S Adr (NVO)
Stryker Corporation (SYK)
AstraZeneca Sponsored Adr (AZN)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Align Technology (ALGN)
Alnylam Pharmaceuticals (ALNY)
Rapport Therapeutics
Syndax Pharmaceuticals (SNDX)
Elanco Animal Health (ELAN)

View all positions for Sofinnova Ventures

Top funds holding IsoRay

ExodusPoint Capital Management
Northern Trust
ADAR1 Capital Management
Atom Investors
RIA Advisory Group
Polymer Capital Management
Ameriprise Financial
Portland Investment Counsel
Thrivent Financial for Lutherans
JDM Financial Group
Wealth Advisors of Iowa
Congress Wealth Management LLC / DE /
Prudential Financial
UBS Group
FMR

View all funds holding IsoRay